Interferons as cytokines regulating leukocyte functions in vivo.
作者信息
Virelizier J L
出版信息
Ann Inst Pasteur Immunol (1985). 1985 Jul-Aug;136D(1):73-7. doi: 10.1016/s0769-2625(85)80078-7.
Abstract
摘要
相似文献
1
Interferons as cytokines regulating leukocyte functions in vivo.干扰素作为在体内调节白细胞功能的细胞因子。
Ann Inst Pasteur Immunol (1985). 1985 Jul-Aug;136D(1):73-7. doi: 10.1016/s0769-2625(85)80078-7.
2
Biologicals for cancer treatment: interferons.用于癌症治疗的生物制品：干扰素。
Hosp Pract (Off Ed). 1985 Dec 15;20(12):71-4, 78-81, 85-6 passim. doi: 10.1080/21548331.1985.11703206.
3
Current view on the perspectives of interferon therapy.干扰素治疗前景的当前观点。
Acta Virol. 1986 Mar;30(2):161-9.
4
Antigenic properties of interferons.干扰素的抗原特性。
Tex Rep Biol Med. 1981;41:23-30.
5
What is the relevance of the various immunomodulatory effects of interferons?干扰素的各种免疫调节作用有何关联？
Ann Inst Pasteur Immunol (1985). 1985 Jul-Aug;136D(1):79-81. doi: 10.1016/s0769-2625(85)80080-5.
6
[Trophoblastic interferons and embryonal immune tolerance].[滋养层干扰素与胚胎免疫耐受]
Contracept Fertil Sex. 1995 Sep;23(9):562-72.
7
Immunological significance of interferon.干扰素的免疫学意义。
Ann Inst Pasteur Immunol (1985). 1985 Jul-Aug;136D(1):81-3. doi: 10.1016/s0769-2625(85)80081-7.
8
Interferon treatment of HEp-2 cells alters the adhesive ability of Pseudomonas aeruginosa.用干扰素处理人喉表皮样癌细胞（HEp-2细胞）会改变铜绿假单胞菌的黏附能力。
APMIS. 1988 Nov;96(11):1043-8. doi: 10.1111/j.1699-0463.1988.tb00979.x.
9
The immunoregulatory importance of interferons in vivo.干扰素在体内的免疫调节重要性。
Ann Inst Pasteur Immunol (1985). 1985 Jul-Aug;136D(1):68-73. doi: 10.1016/s0769-2625(85)80077-5.
10
Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons.社论：I型和III型干扰素的结构、信号传导机制及功能
Front Immunol. 2021 Feb 18;12:638479. doi: 10.3389/fimmu.2021.638479. eCollection 2021.
引用本文的文献
1
Carbon dots from purple sweet potato as a promising anti-inflammatory biomaterial for alleviating the LPS-induced inflammation in macrophages.紫甘薯来源的碳点作为一种有前景的抗炎生物材料，用于减轻巨噬细胞中脂多糖诱导的炎症。
J Nanobiotechnology. 2025 May 30;23(1):397. doi: 10.1186/s12951-025-03494-9.
本文引用的文献
1
Murine genotype influences the in vitro production of gamma (immune) interferon.小鼠基因型影响γ（免疫）干扰素的体外产生。
Eur J Immunol. 1982 Nov;12(11):988-90. doi: 10.1002/eji.1830121119.
2
3
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.鉴定γ干扰素为激活人类巨噬细胞氧化代谢和抗菌活性的淋巴因子。
J Exp Med. 1983 Sep 1;158(3):670-89. doi: 10.1084/jem.158.3.670.
4
Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes.干扰素作为巨噬细胞激活因子。II. 脂多糖刺激的人单核细胞白细胞介素1分泌增强。
Eur J Immunol. 1983 Jun;13(6):437-40. doi: 10.1002/eji.1830130602.
5
[Deficiencies of interferon production in children].[儿童干扰素生成缺陷]
Presse Med. 1984 Feb 25;13(8):495-8.
6
Interferon: pharmacokinetics and toxicity.干扰素：药代动力学与毒性
Philos Trans R Soc Lond B Biol Sci. 1982 Sep 24;299(1094):91-107. doi: 10.1098/rstb.1982.0109.
7
Human newborns are deficient in natural killer activity.人类新生儿的自然杀伤活性不足。
J Clin Immunol. 1982 Oct;2(4):350-5. doi: 10.1007/BF00915078.
8
[Increase of viral pathogenicity by use of anti-interferon serum in vivo].[体内使用抗干扰素血清增加病毒致病性]
C R Acad Hebd Seances Acad Sci D. 1970 Oct 19;271(16):1464-6.
9
10
Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality.人类新生儿中干扰素-γ产生缺陷。I. 调节异常而非内在异常。
J Immunol. 1985 Jan;134(1):167-71.
Zotero 插件